Guri Grimnes

M.D., Ph.D.

Workplace:

University Hospital of North Norway

Employer:

University of Tromsø

Areas of interest:

Clinical and epidemiological aspects of hormones, and in particular vitamin D. The relation between vitamin D status and lifestyle related diseases like osteoporosis, diabetes and cardiovascular disease.

_______________________________________________________________________________________

CV

Current position

Medical Doctor in the Medical Division, University Hospital of North Norway
Associate Professor at the Department of Clinical Medicine, University of Tromsø

Basic profession

Physician, training to be endocrinologist

Academic degrees

Ph.D., 2011
Cand. med., 1998

Dissertation

Clinical and laboratory aspects of vitamin D in relation to type 2 diabetes and osteoporosis (2011)

Awards

Young Investigator Award at the American Society for Bone and Mineral research (ASBMR) topical meeting in 2007 for the poster “The Association between Thyroid Stimulating Hormone and Bone Mineral Density in Men and Postmenopausal Women – a Cross-Sectional Population Study”.

Peer review

Cell Biochemistry and Function

_______________________________________________________________________________________

Publications

(right-click and open in new tab to access external websites)

Publications in PubMed

Selected publications

Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R. (2010) Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during eleven years of follow-up. Diabet Med 27:1107-15

Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. (2010) High serum 25-hydroxyvitamin D concentrations are associated with a favourable lipid profile. Eur J Clin Nutr Sep 8. [Epub ahead of print]

Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock L, Hutchinson M, Methlie P, Mihailova A, Sneve M, Torjesen P, Wilsgaard T, Jorde R. (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 163:339-48

Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in a intervention study. Am J Epidemiol 171:903-8

Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G. (2010) Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr 49:401-7

Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. (2010) Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø Study. Eur J Endocrinol 162:935-42

Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G. (2010) Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict hypertension. Hypertension 55:792-8

Jorde R, Sneve M, Torjesen P, Figenschau Y, Hansen JB, Grimnes G. (2010) No significant effect on bone mineral density by high doses of vitamin D3 given to obese or overweight subjects for one year. Nutr J, 9:1

Emaus N, Omsland TK, Ahmed LA, Grimnes G, Sneve M, Berntsen GK. (2009) Bone Mineral Density at the hip in Norwegian women and men – prevalence of osteoporosis depends on chosen references: the Tromsø Study. Eur J Epidemiol 24:321-8

Wilsgaard T, Emaus N, Ahmed LA, Grimnes G, Joakimsen R, Omsland T.K, Berntsen GR. (2009) Lifestyle impact on lifetime bone boss in women and men. The Tromsø Study, a population-based study. Am J Epidemiol 169:877-86

Grimnes G, Emaus N, Figenschau Y, Joakimsen R and Jorde R. (2008) The relationship between TSH and bone mineral density in men and postmenopausal women. The Tromsø Study. Thyroid 18:1147-55

← Back to researchers





Norwegian Epidemiologic Osteoporosis Studies | E-mail: norepos@fhi.no